Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective

Table 3

Utility multipliers by fracture type and adverse event.

Fracture type/period	Utility multiplier	Source
First year after fracture
Hip fracture	0.700	Peasgood et al. 2009 [36]
Clinical vertebral fracture	0.590	Peasgood et al. 2009 [36]
NHNV fractures	0.902	Kanis et al. 2004 [37]
The second year and following years after fracture
Hip fracture	0.800	Peasgood et al. 2009 [36]
Clinical vertebral fracture	0.930	Borgström et al. 2006 [38]